NCT03837457: A trial that was reported late by miRagen Therapeutics, Inc.
This trial has reported, although it was 4 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03837457 |
|---|---|
| Title | PRISM: An Open-label, Multi-Center Extension Study to Investigate the Efficacy and Safety of Cobomarsen (MRG-106) Following Systemic Treatment in Subjects With Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides (MF) Subtype, Who Have Completed the SOLAR Study |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Oct. 1, 2019 |
| Completion date | July 24, 2020 |
| Required reporting date | July 24, 2021, midnight |
| Actual reporting date | July 28, 2021 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 4 |